TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTOR-I AND RECEPTOR-II AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE PYELONEPHRITIS IN RELATION TO BACTERIAL VIRULENCE-ASSOCIATED TRAITS AND RENAL-FUNCTION
Sh. Jacobson et al., TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTOR-I AND RECEPTOR-II AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE PYELONEPHRITIS IN RELATION TO BACTERIAL VIRULENCE-ASSOCIATED TRAITS AND RENAL-FUNCTION, Nephrology, dialysis, transplantation, 11(11), 1996, pp. 2209-2214
Urinary tract infections activate both mucosal and systemic inflammato
ry responses reflected by elevation of cytokine concentrations in seru
m and urine, We determined urine and serum concentrations of tumour ne
crosis factor soluble receptors I and II (sTNFR I and sTNFR II) and in
terleukin-l receptor antagonist (IL-1ra) in 41 women with acute pyelon
ephritis caused by Escherichia coli, 2 weeks after the infection, duri
ng a subsequent episode of cystitis or asymptomatic bacteriuria and al
so later when the same patients were free from bacteriuria. Concentrat
ions of sTNFR I, sTNFR II and IL-1ra were related to the expression of
five virulence markers of E. coli, glomerular filtration rate (GFR) a
nd to the concentration of C-reactive protein (CRP) in serum. Patients
with acute pyelonephritis had elevated serum concentrations of sTNFR
I and sTNFR II compared to healthy women (P<0.001 for both comparisons
). The concentrations of sTNFR I and sTNFR II in urine were significan
tly higher in patients with acute pyelonephritis compared to controls
(P<0.001 in both cases). The concentration of sTNFR II in urine was hi
gher in patients infected by E. coli producing haemolysin (P=0.05) and
in patients infected by E. coli expressing hydrophobic properties (P=
0.05) compared to patients infected by strains without these virulence
traits. Patients who had high concentrations of sTNFR II in serum dur
ing acute pyelonephritis had lower GFR at follow-up (r=-0.48, P=0.05).
Patients who responded with a marked increase in CRP had higher sTNFR
I and sTNFR II in urine (r=0.58, P<0.01 and r=0.48, P<0.01, respectiv
ely), The concentrations of sTNFR I and sTNFR II in serum and urine de
creased during follow-up and were lower 2 weeks after the infection wh
en all patients were free from bacteriuria. IL-1ra in serum was elevat
ed during pyelonephritis (P<0.001) while that in urine was significant
ly lower compared to controls (P<0.001). It is concluded that the incr
eased concentrations of TNF receptors may block the cytotoxic and infl
ammatory actions and reduce the sensibility of renal cells to TNF alph
a-mediated effects.